PD-1/PD-L1 pathway blockade in a murine mucormycosis model successfully suppressed the targeted molecules and co-suppressed CTLA-4 but led to rapid upregulation of TIM-3 within 4 days of ICI initiation (51). The gene discussed is CD274; the disease is Zygomycosis.